Connect with us

Hi, what are you looking for?

Thursday, Apr 25, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Business

Rubicon receives global certification standard for medical cannabis production

The Control Union has declared the products are compliant with World Health Organization (WHO) guidelines

Rubicon receives certification standard for medical cannabis production
Photo via Rubicon Organics

Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) has received a global standard certification for its medical cannabis cultivation in Delta.

On Wednesday, the company said it was granted the CUMCS Equivalency IMC-Good Agricultural Practices (GAP) certification by the Control Union Medical Cannabis Standard GAP (CUMCS-GAP) which is the leading certification standard for medical cannabis production globally.

Through the certification, the Control Union has declared that the company’s cannabis products are compliant with the World Health Organization (WHO) guidelines on Good Agricultural Practices (GACP) Medicinal Plants, the European Medicines Agency’s (EMEA), Guideline on GACP for Herbal Medical Products, and the Israeli Medical Cannabis GACP.

Control Union Canada Inc. is a member of the Peterson Control Union Group which has operations in over 85 countries. It supports and audits commodities certifications and process standards for biofuels, sugar, palm oil, soy and many other commodities.

Read more: Rubicon Organics reports record revenue in Q3

Read more: Rubicon Organics inks first medical deal with Shoppers Drug Mart

“Rubicon Organics has achieved an important milestone for international export with the Certification as it allows Rubicon to export our products internationally and is a key step in delivering on our vision to be the global brand leader in premium organic cannabis,” Rubicon CEO Jesse McConnell said in a statement.

Rubicon is a vertically integrated licensed producer that sells high-quality organize dried flower under the brand Simply Bare as well as hash under the 1964 Supply Co brand, concentrates through LAB THEORY and its mainstream brand Homestead Cannabis Supply.

Last September, the company partnered up with Shoppers Drug Mart Inc. to offer its products to medical patients signed to the Medical Cannabis by Shoppers Drug Mart platform.

Company stock stayed flat on Friday at $0.93 on the Canadian Venture Exchange.

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Business

This month, the company reported a Q2 net revenue increase of 92% year-over-year

Business

Rubicon’s national market share of premium flower and pre-rolls dipped to 7.1 per cent during the first quarter from 7.6 per cent during Q4...

Business

The firm says it had its first EBITDA-profitable month in September

Business

Shoppers-registered patients will be able to buy Simply Bare Organic hash as well as Wildflower Cool and Relief sticks